Benefits and risks evaluation of recombinant human growth hormone replacement therapy in children with GHD after craniopharyngioma surgery.

Li-Li Pei,Ying Guo,Han Chen,Li-Yong Zhong

Journal of pediatric endocrinology & metabolism : JPEM（2023）

引用 1|浏览8

暂无评分

摘要

GHRT effectively accelerates GV, increases HtSDS, and improves lipid profiles without unfavorable effects on glucose metabolism. The benefits are clear and the risks of adverse events are low.

查看译文

关键词

children,craniopharyngioma,growth hormone deficiency,human growth hormone

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要